Authors:
LYON AW
MEINERT P
BRUCE GA
LAXDAL VA
SALKIE ML
Citation: Aw. Lyon et al., INFLUENCE OF METHODOLOGY ON THE DETECTION AND DIAGNOSIS OF CONGENITALANALBUMINEMIA, Clinical chemistry, 44(11), 1998, pp. 2365-2367
Citation: Aw. Lyon et al., USE OF THROMBIN INHIBITORS EX-VIVO ALLOWS CRITICAL CARE CLINICAL-CHEMISTRY AND HEMATOLOGY TESTING ON COMMON SPECIMENS, Clinical biochemistry, 30(2), 1997, pp. 121-127
Citation: Dw. Drobot et al., USE OF A THROMBIN INHIBITOR D-PHENYLALANYL-L-PROLYL-L-ARGININE CHLOROMETHYL KETONE (PPACK), WITH A FACTOR-XA INHIBITOR, 1,5-DANSYL-L-GLUTAMYL-L-GLYCYL-L-ARGININE CHLOROMETHYL KETONE (GGACK) FOR ANTICOAGULATIONOF CLINICAL-CHEMISTRY SPECIMENS, Clinical chemistry, 42(6), 1996, pp. 757-757
Citation: Aw. Lyon et al., EVALUATION OF CONCORD(R) CALCIUM NEUTRALIZED DRY LITHIUM HEPARIN PRO-VENT(TM) BLOOD-GAS SYRINGES FOR DETERMINATION OF BLOOD-GASES, ELECTROLYTES AND IONIZED CALCIUM, Clinical chemistry, 42(6), 1996, pp. 762-762
Citation: Jt. Hindmarsh et Aw. Lyon, STRATEGIES TO PROMOTE RATIONAL CLINICAL-CHEMISTRY TEST UTILIZATION, Clinical biochemistry, 29(4), 1996, pp. 291-299
Citation: Me. Lyon et al., D-PHENYLALANYL-L-PROLYL-L-ARGININE CHLOROMETHYL KETONE (PPACK) - ALTERNATIVE ANTICOAGULANT TO HEPARIN SALTS FOR BLOOD-GAS AND ELECTROLYTE SPECIMENS, Clinical chemistry, 41(7), 1995, pp. 1038-1041
Citation: Aw. Lyon et al., DETERMINATION OF THALIDOMIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - METHODOLOGICAL STRATEGY FOR CLINICAL-TRIALS, Clinical biochemistry, 28(4), 1995, pp. 467-470
Citation: Aw. Lyon et al., A STRATEGY TO PROMOTE RATIONAL CLINICAL-CHEMISTRY TEST UTILIZATION, American journal of clinical pathology, 103(6), 1995, pp. 718-724
Citation: Aw. Lyon et al., IN-VIVO ANALYSIS OF MURINE SERUM SULFATE METABOLISM AND SPLENIC GLYCOSAMINOGLYCAN BIOSYNTHESIS DURING ACUTE-INFLAMMATION AND AMYLOIDOSIS, Journal of rheumatology, 20(7), 1993, pp. 1108-1113